Drug Shortage Report for PMS-LAMOTRIGINE
Report ID | 79855 |
Drug Identification Number | 02246899 |
Brand name | PMS-LAMOTRIGINE |
Common or Proper name | LAMOTRIGINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | LAMOTRIGINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2019-03-27 |
Estimated end date | 2019-06-03 |
Actual end date | 2019-07-29 |
Shortage status | Resolved |
Updated date | 2019-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-07-31 | French | Compare |
v7 | 2019-07-31 | English | Compare |
v6 | 2019-06-28 | French | Compare |
v5 | 2019-06-28 | English | Compare |
v4 | 2019-06-11 | French | Compare |
v3 | 2019-06-11 | English | Compare |
v2 | 2019-03-29 | French | Compare |
v1 | 2019-03-29 | English | Compare |
Showing 1 to 8 of 8